Scaling up prevention, testing and treatment services could eliminate hepatitis C as a public health threat. The World Health Organization’s target is for countries to reduce infections by 90% and hepatitis-related mortality by 65%, by 2030.

Elimination of hepatitis C: latest news

Elimination of hepatitis C news from aidsmap

More news

Elimination of hepatitis C news selected from other sources

  • Egypt proposes plan to treat African Hepatitis C patients

    Minister of Health Hala Zayed unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries who have an estimated 3.7 million hepatitis C patients, representing 30 percent of the total number of infected people in Africa.

    16 January 2019 | Egypttoday
  • Hepatitis C in England: 2018 report

    In this report, we summarise the impact of action plans in England to drive down mortality from HCV, reduce the number of new infections, and outline the actions required to make further progress.

    08 May 2018 | Public Health England
  • Eliminating Hepatitis C in England

    England will not fulfil its commitment to elimination of hepatitis C by 2030 unless the number of people diagnosed and initiated onto treatment is greatly increased.

    23 March 2018 | All-Party Parliamentary Group on Liver Health
  • Systematic Hep C Test-and-Treat Lowers Rate in Gay Men With HIV

    A Swiss research program tested for and treated hep C in a large cohort of HIV-positive men who have sex with men over time.

    22 March 2018 | Poz
  • WHO urges countries to scale up hepatitis C treatment

    A new WHO report shows that the annual number of people receiving hepatitis C cure increased from around 1 million in 2015 to 1.5 million in 2016. However, global access to hepatitis C treatment remains uneven, with Egypt and Pakistan accounting for about half of all people starting direct-acting antiviral (DAA) treatment to cure hepatitis C in 2016.

    09 March 2018 | World Health Organization
  • Hepatitis C drugs not being accessed by thousands of Australians with the disease

    Hundreds of thousands of Australians with hepatitis C are failing to access new curative drugs, despite the Government subsidising them at huge cost to the taxpayer. The trend means the Government is at risk of missing its target to eradicate hepatitis C and of spending far more than necessary on the treatments.

    12 February 2018 | ABC News
  • US: New Hepatitis C Infections Nearly Tripled over Five Years

    Over just five years, the number of new hepatitis C virus infections reported to CDC has nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released today by the Centers for Disease Control and Prevention (CDC).

    12 May 2017 | CDC
  • New report halves the number of people infected with hepatitis C worldwide

    A new World Health Organization (WHO) report chops the estimated number of people around the world living with the liver-damaging hepatitis C virus (HCV) in half—but the drop has nothing to do with the recent advent of powerful drugs that cure the disease for most everyone. The dramatic drop occurred primarily because of tests that measured HCV’s genetic material, RNA, in people. Previous epidemiological surveys tested whether people had antibodies against the virus, which is less precise.

    02 May 2017 | Science
  • New hepatitis data highlight need for urgent global response

    New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.

    21 April 2017 | World Health Organization
  • Taking stock: Where does Europe stand in the elimination of hepatitis B and C?

    In 2016, a regional action plan for Europe contributing to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, the authors take a closer look how Europe is doing according to the ten indicators and targets outlined in this plan.

    03 March 2017 | EurekAlert (press release)
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.